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Pharmaceutical oral liquid dosage forms are basically formulated as non
however, must satisfy the appropriate microbiological purity criteria.
pharmaceutical products are susceptible to contamination by a variety of microorganisms 
during manufacturing and use. In this study, sixty seven (67) samples of four (4) 
different pediatric oral liquid drugs (
cotrimoxazole suspensions) were 
using standard procedures described in the official monograph of the British and United 
Stated pharmacopoeia.  Microbial contamination was observed in 44 (65.7%) of the 
tested samples with 25 (37.3%) and 17 (25.4%) of the examined products having Total 
Aerobic Microbial Counts (TAMC) and Total Yeasts Moulds Counts (TYMC) 
the USP and BP acceptable limit
microbial contamination was observed in samples of pediatric oral liquid formulations 
particularly in samples of Ibuprofen and metronidazole suspensions.
contaminants recovered from the examined products include 
aureus, Micrococcus sp., Pseudomonas aeruginosa, Enterobacter sp., Escherichia coli, 
Penicillium sp., Aspergillus sp., and Candida sp.
current good manufacturing practices and good hygienic practices during handling, sales 
and usage of the products is recommended. 
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INTRODUCTION 
Pharmaceutical products of different forms and 
dosage are susceptible to contamination by a 
variety of microorganisms during manufacturing, 
storage, handling or use by the consumer
et al., 2004; Oviasogie et al., 2015)
forms such as aqueous solutions, suspensions, 
emulsions, syrups and tablets are among the 
preparations that are at the greatest risk of 
microbial contamination (Netish et al.,
a result of the lack of good manufacturing 
practices, liquid dosage forms being non
are likely to contain different types of microbial 
species. Additionally, pharmaceutical products 
that contain moderate to high water activity, 
products containing sweeteners and products in 
multidose containers are more prone to 
microbial contamination (Atata et al.,
Thus, moisture and a high amount of sugar in 
the oral liquid drugs in particular can support 
microbial growth (Khanom et al., 2013). 
et al. (2018) further emphasized that 
percentage level of sucrose contained in 
dosage forms especially syrups, makes them 
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Several studies have reported cases of microbial 
contamination of liquid dosage forms. 
Moniruzzaman et al. (2012) reported microbial 
contamination in antacids and paracetamol 
samples from different drug stores of Dhaka, 
Bangladesh, with 75% of the antacid and 60% 
of the paracetamol samples showing microbial 
count exceeding the USP limit. In another study 
that investigated the microbial contamina
brands of multivitamin syrups marketed in 
Maiduguri metropolis, Borno State, 
(2012) reported that one out of the seven 
different samples contains pathogenic organisms 
while the other six samples contain non
pathogenic organisms, but were below the limit 
count set by the microbiological quality of 
syrups. Similarly, a study by Adeshina 
(2009) has shown that among some pediatric 
anti-malarial and cough preparations sold in 
retail outlets in Ilorin, Nigeria, 14 (70%) were 
heavily contaminated and exceeded the official 
tolerance limit (Greater than 10
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Some of the preparations were contaminated 
with Bacillus subtilis, Escherichia coli, 
Staphylococcus aureus, and Pseudomonas 
aeruginosa. 
Microbial contaminants when present in non-
sterile preparations can result in several 
undesirable consequences that ranged from 
spoilage resulting to physical and chemical 
changes, risk of infection to the consumer as 
well as products recalls and business loss 
(Calistus et al., 2011; Oviasogie et al., 2015). 
Such changes in the physical and chemical 
characteristics of contaminated pharmaceuticals 
include breaking of emulsions, thinning of 
creams, and fermentation of syrups, appearance 
of turbidity or deposit. Likewise, alterations in 
the organoleptic properties of the drugs such as 
changes odour, colour, and taste, thus rendering 
them unacceptable to the patients 
(Moniruzzaman et al., 2012). 
Furthermore, microbial contaminants when 
present in non-sterile preparations can possibly 
reduce or even inactivate the therapeutic activity 
of the product (United States Pharmacopoeia, 
2009). Use of such kind of products even when 
the level of contamination is low is also 
considered to be microbiologically unsafe 
because it may present potential health hazards 
to patients (Essam et al., 2012). There have 
been several published reports describing clinical 
hazards that are attributable to microbiologically 
contaminated pharmaceuticals (Mugoyela and 
Mwambete, 2010). 
Pharmaceutical formulations of Syrups and 
suspensions contain sweetening agents and 
other excipients that make them susceptible to 
microbial contamination even when stored at 
particular conditions (Sudeshika et al., 2014). 
Increased attention is needed on the 
microbiological quality of liquid oral formulations 
because these represent the most common 
category of drugs that are administered to 
pediatric patients whose immune system is yet 
matured.  This study therefore aimed at 
investigating the presence of microbial 
contamination in oral liquid drugs obtained from 
hospitals and patent medicine stores in Katsina 
State, Nigeria.  
 
MATERIALS AND METHODS 
Collection and processing of drug samples  
A total of sixty seven (67) samples of four (4) 
different pediatric oral liquid drugs were 
obtained from the hospital, private pharmacies 
and patent medicine stores randomly selected 
within the state. The samples included liquid 
formulations of Ibuprofen, Albendazole, 
Metronidazole and cotrimoxazole suspensions. 
Prior to opening of the samples, the outside 
surfaces of sample containers such head cap of 
the oral suspensions were wiped with 70% v/v 
ethanol as described by Shaqra et al.,( 2014).  
Ten  (10 ml) of the products to be examined 
were diluted in 90ml of Trypticase Soy Broth 
(TSB) and serially diluted to get ten-fold 
dilutions of 101-105. 
Assessment of microbial contamination 
Microbial Enumeration Tests: One (1ml) of 
the first three (101-103) dilutions of each test 
samples was inoculated onto plates of casein 
soya bean digest agar (CSBDA) and incubated at 
37°C for 3–5 days, and Sabouraud-dextrose 
agar at 25 °C for 5–7 days. After the incubation 
period, colonies were counted and the results 
were expressed as colony forming units per 
milliliter (cfu/ ml) of the sample (United States 
Pharmacopeia, 2018). 
Isolation and identification of bacterial 
contaminants 
After the incubation period, colonies were sub 
cultured on the MacConkey agar, Salmonella 
Shigella agar, Mannitol salt agar and Nutrient 
agar plate to get pure culture for identification. 
Gram staining and microscopy, an array of 
biochemical tests which include catalase, 
coagulase, oxidase, indole, citrate utilization, 
Voges prauskeur test, methyl red, urease 
production, motility was carried out as described 
by Cheesbrough (2006). 
Identification of fungal contaminants 
Fungal growths from the SDA plate were 
identified using colonial morphology such as 
growth pattern, pigmentation and size of 
colonies. Further identification was achieved by 
lactophenol blue stain and microscopically 
(Davise, 2012).   
 
RESULTS 
The results of the assessment of the microbial 
contamination of the analyzed oral drug samples 
as depicted on Figure 1 revealed the presence of 
microbial contamination in 44 (65.7%) of the 
tested samples, of which 12 (27.3%) samples 
even though were contaminated, complied with 
the USP and BP acceptance criteria of non-sterile 
oral preparations while 32 samples were heavily 
contaminated above the acceptable limit. 
Microbial loads in the tested samples, as shown 
in Table 1, showed that 25 (37.3%) of the 
examined products had total aerobic microbial 
count greater than 102 cfu/ml. Ibuprofen 
suspension had the highest percentage of 
samples (45.0%) with total aerobic microbial 
count greater than 102 cfu/ml, followed by 
samples of metronidazole suspensions of which 
41.2% had total aerobic microbial count greater 
than 102 cfu/ml.  
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On the other hand, the proportions of the tested 
samples having total yeast and mould count 
greater than 101 cfu/ml was 17 (25.4%).  
Similarly, samples of ibuprofen suspension had 
the highest percentage of samples (35.0%) with 
total yeast and mould count greater than 101 
cfu/ml, followed by samples of metronidazole 
suspensions of which 29.4% had total aerobic 





Figure 1: Percentage contamination of some pediatric oral liquid formulations sold 
in Katsina State, Nigeria. 
 
 
Table 1: Microbial Load (cfu/mL) in the Tested Samples 
 
Drug type No. of Samples 
Tested 
Total Aerobic Microbial 
Count > 102 cfu/ml 
   
 N                   % 
Total Yeast and Mould 
Count > 101 cfu/ml 
        
        N                   % 
Albendazole suspension 13 03 23.1 02 15.4 
Ibuprofen suspension 20 09 45.0 07 35.0 
Cotrimoxazole suspension 17 06 35.3 03 17.6 
Metronidazole suspension 17 07 41.2 05 29.4 
Total 67 25 37.3 17 25.4 
N-number 
 
Distribution of microbial contaminants 
from the tested products 
The different oral liquid preparations were found 
to be contaminated with various microbial 
species of bacteria and fungi. In general, 63 
microbial contaminants were successfully 
identified, of which 42 (66.7%) were bacteria 
and the remaining, 21 (33.3%) were fungi. 
Table 2 presents the distribution of the identified 
bacterial contaminants recovered from the 
tested preparations. The most frequently found 
bacterial contaminants were Bacillus species, 12 
(28.6%) followed by Staphylococcus sp. Other 
bacterial contaminants recovered include 
Micrococcus sp., Pseudomonas aeruginosa, 
Enterobacter sp., Escherichia coli and Klebsiella 
sp. While table 3 present the percentage 
occurrence of the fungal isolates, Candida sp., 
were the predominant fungal contaminants, 09 









No. of Samples Analysed Contaminated Contaminated & non compliant Contaminated & compliant
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Table 2: Distribution of the bacterial contaminants recovered for the tested preparations 
Bacterial isolate Number Percentage (%) 
Bacillus sp. 12 28.6.0 
Staphylococcus aureus 05 11.9 
Other Staphylococcus sp. 07 16.7 
Micrococcus sp. 03 7.1 
Pseudomonas aeruginosa 04 9.5 
Escherichia coli 02 4.8 
Enterobacter sp. 04 9.5 
Klebsiella sp. 03 7.1 
Citrobacter sp. 02 4.8 
Total   42 100 
 
Table 3: Distribution of fungal contaminants recovered for the tested preparations 
Fungal isolate Number Percentage (%) 
Aspergillus flavus 04 19.0% 
Aspergillus niger 03 14.3% 
Penicillium sp. 05 23.8% 
Candida sp. 09 42.9% 
Total   21 100% 
 
DISCUSSION 
The occurrence of microbial contamination of 
65.7% in the tested non-sterile pharmaceutical 
oral drug formulations in this study is 
comparable to the results of other studies: 
Calistus et al, (2011) reported microbial 
contamination in 62.5% and 55.5% of 
metronidazole and co-trimoxazole suspensions 
sourced from different locations in South-
Eastern Nigeria. 
 The prevalence of microbial contamination 
observed in our study is much lower than the 
report of other studies. In related work, Khanom 
et al. (2013) evaluated the microbial 
contaminations of liquid oral drugs available in 
Bangladesh, comprising 26 syrups and 14 
suspensions. It was reported that all the 
samples, except one syrup were found to be 
contaminated with bacteria and fungi. Similarly, 
in another study by Fatema, (2014) on the 
assessment of microbiological quality of the 
pediatric oral liquid drugs in Dhaka metropolis in 
Bangladesh reported that all the 20 (100%) 
samples were found to be highly contaminated 
with bacteria. Moreover, Daniyan and Sangodere 
(2011) reported that 72.2% of pediatric syrup 
preparations sold in patent medicine stores in 
Minna metropolis, Nigeria, were heavily 
contaminated with bacteria and fungi.  On the 
other hand, lower incidence of microbial 
contamination has been reported, Tamalli et al. 
(2013) reported microbial contamination in 
21.6% of the tested syrups and 26.7% in tablets 
commonly used at Alkhoms Market, Libya.  
In this study, Bacillus species accounted for the 
majority of microbial contaminant in the tested 
samples. Bacillus species have been reported as 
the predominant contaminant of non-sterile  
 
pharmaceutical products by other studies 
conducted in different areas of the world such 
as; Adeshina et al. (2009) reported Bacillus 
subtilis as the most predominant contaminants 
in different brands of paediatric anti-malaria and 
cough preparations sold in Ilorin, Nigeria.  
Similarly, Mugoyela and Mwambete, (2010) in 
Tanzania reported that the majority of microbial 
contaminants isolated from non-sterile 
pharmaceuticals were Bacillus spp. In a related 
work from Benin, Nigeria, Akerele and Godwin 
(2002) reported the isolation of Bacillus species 
as the major contaminant of pharmaceutical 
products. their presence in a product suggests 
poor environmental hygiene during  
manufacturing, distribution and storage (Willey 
et al., 2008) or as heavily contaminated or 
adulterated raw materials (Mugoyela and 
Mwambete, 2010). 
The implication of microbial contamination of 
non-sterile pharmaceutical products with Bacillus 
species is that even though most species are 
non-pathogenic, several studies have shown that 
their presence in non-sterile pharmaceutical 
products is undesirable because of their spoilage 
potential, it can reduce the potency and 
therapeutic activity of the products with their 
potential adverse effects to the patients taking 
such medicaments (Mugoyela and Mwambete, 
2010; Adeola et al., 2012). 
In this study, Staphylococcus aureus, other 
coagulase negative Staphylococcal sp. and 
microccoccus sp. accounted for about 28.0% of 
the bacterial species recovered from the tested 
dosage forms. Agbulu et al, (2016) reported the 
isolation of Staphylococcus aureus in addition to 
Pseudomonas sp. in cough syrups produced by 
different pharmaceutical companies sourced 
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from pharmacy shop in Benue State, Nigeria. In 
a related study in Bangladesh, Fatema (2014), 
reported Staphylococcus species as the most 
predominant microbial contaminant in paediatric 
oral liquid drugs. The presence of 
Staphylococcus species in non-sterile oral 
pharmaceutical products could be attributed to 
unhygienic handling of the products, or possibly 
contamination from the equipment and/or raw 
materials (Gad et al. 2011).  
Pseudomonas aeruginosa was recovered from 
three samples of syrups and suspensions. These 
involved two samples Ibuprofen and one 
samples of Cotrimoxazole suspensions. 
Contamination of non-sterile pharmaceutical 
products with Pseudomonas species has been 
reported worldwide. Jimenez (2007) had 
reported Pseudomonas aeruginosa as the most 
frequently found contaminant in pharmaceutical 
products from all over the world. The presence 
of Pseudomonas aeruginosa in non-sterile 
pharmaceutical products possibly reflects 
contamination of the raw materials used as well 
as the conditions of the manufacturing 
environment in which the products are 
manufactured and packaged (Rania et al., 
2013). 
The presence of Escherichia coli, Enterobacter 
species and other members of the 
enterobacteriaceae in some of the tested 
preparations is a good indicator of faecal 
contamination which may be principally from 
production personnel or from water supply 
(Adeshina et al., 2009). In this study, one 
sample each of Cotrimoxazole and Metronidazole 
suspensions showed the presence of Escherichia 
coli and therefore failed the qualitative test for 
the absence of objectionable microorganism in 
non-sterile oral dosage forms. The presence of 
Escherichia coli is objectionable in oral dosage 
forms as clearly stated by the pharmacopoeias 
worldwide (BP, USP, European pharmacopoeia 
and the International pharmacopoeia) because 
its presence is an indication of pathogenic 
contamination of the products.  
In this study, the identified fungal contaminants 
were mainly moulds which comprised of 
Penicillium sp., Aspergillus flavus and Aspergillus 
niger while Candida sp. was the only identified 
yeast. Fungal contamination of pharmaceutical 
products is undesirable because they can 
produce metabolites/toxins that may be harmful 
to the consumers and additionally can cause 
deterioration of the products due to the 
biodegradation of the various components that 
constitute the formulation, and thus interfere 
with the therapeutic function of the product 
(Gad et al., 2011). 
 
CONCLUSION AND RECOMMENDATION 
High level of microbial contamination was 
observed in samples of pediatric oral liquid 
formulations particularly in samples of Ibuprofen 
and metronidazole suspensions. Moreover, 
bacterial contamination was the most common 
among the tested samples.  
Thus stringent quality control processes and 
compliance with the guidelines of the current 
good manufacturing practices during the 
manufacture, storage, distribution of these 
products is recommended. Also there should be 
good hygienic practices during handling, sales 
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